STAAR Surgical defends merger process amid activist criticism
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
December 11, 2025 9:47 AM ESTActivist Investors Have Twisted Facts Regarding STAARs Engagement with a Potentially Interested Party During Go-Shop Process
The Potentially Interested Party Reached Out on Day 21 of 30-Day Go-Shop Process and Refused to Sign an NDA Even without a Standstill
Broadwood Partners and Yunqi Capital Continue to Distort the Truth for Their Own Benefit
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL) for vision... More



